-
1
-
-
83755219473
-
Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review
-
Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142(1): 46Y54
-
(2012)
Gastroenterology
, vol.142
, Issue.1
, pp. 46-54
-
-
Molodecky, N.A.1
Soon, I.S.2
Rabi, D.M.3
-
2
-
-
84875276180
-
Ecco yepicom the burden of inflammatory bowel disease in europe
-
Burisch J, Jess T, Martinato M, Lakatos PL; ECCO YEpiCom. The burden of inflammatory bowel disease in Europe. J Crohns Colitis 2013;7(4):322Y37
-
(2013)
J Crohns Colitis
, vol.7
, Issue.4
, pp. 322-337
-
-
Burisch, J.1
Jess, T.2
Martinato, M.3
Lakatos, P.L.4
-
3
-
-
84886014303
-
Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: Lessons learned from animal models and human genetics
-
Pastorelli L, De Salvo C, Mercado JR, et al. Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: Lessons learned from animal models and human genetics. Front Immunol 2013;4:280
-
(2013)
Front Immunol
, vol.4
, pp. 280
-
-
Pastorelli, L.1
De Salvo, C.2
Mercado, J.R.3
-
4
-
-
84887552451
-
European evidence based consensus for endoscopy in inflammatory bowel disease
-
Annese V, Daperno M, Rutter MD, et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis 2013;7(12):982Y1018
-
(2013)
J Crohns Colitis
, vol.7
, Issue.12
, pp. 82-118
-
-
Annese, V.1
Daperno, M.2
Rutter, M.D.3
-
5
-
-
80053130162
-
Results of the 2nd part scientific workshop of the ecco ii: Measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease
-
Daperno M, Castiglione F, de Ridder L, et al. Results of the 2nd part Scientific Workshop of the ECCO. II: Measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease. J Crohns Colitis 2011;5(5): 484Y98
-
(2011)
J Crohns Colitis
, vol.5
, Issue.5
, pp. 484-498
-
-
Daperno, M.1
Castiglione, F.2
De Ridder, L.3
-
6
-
-
84869846163
-
Challenges to the design, execution, and analysis of randomized controlled trials for inflammatory bowel disease
-
D'Haens G, Feagan B, Colombel JF, et al. Challenges to the design, execution, and analysis of randomized controlled trials for inflammatory bowel disease. Gastroenterology 2012;143(6):1461Y9
-
(2012)
Gastroenterology
, vol.143
, Issue.6
, pp. 1461-1469
-
-
D'Haens, G.1
Feagan, B.2
Colombel, J.F.3
-
7
-
-
84887210548
-
Clinical implications of mucosal healing in the management of patients with inflammatory bowel disease
-
Orlando A, Guglielmi FW, Cottone M, et al. Clinical implications of mucosal healing in the management of patients with inflammatory bowel disease. Dig Liver Dis 2013;45(12):986Y91
-
(2013)
Dig Liver Dis
, vol.45
, Issue.12
, pp. 86-91
-
-
Orlando, A.1
Guglielmi, F.W.2
Cottone, M.3
-
8
-
-
84867027990
-
Mucosal healing in inflammatory bowel diseases: A systematic review
-
Neurath MF, Travis SP. Mucosal healing in inflammatory bowel diseases: A systematic review. Gut 2012;61(11):1619Y35
-
(2012)
Gut
, vol.61
, Issue.11
, pp. 619-635
-
-
Neurath, M.F.1
Travis, S.P.2
-
9
-
-
84861338466
-
Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: A prospective, multicenter study
-
Meucci G, Fasoli R, Saibeni S, et al. Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: A prospective, multicenter study. Inflamm Bowel Dis 2012;18(6):1006Y10
-
(2012)
Inflamm Bowel Dis
, vol.18
, Issue.6
, pp. 1006-1010
-
-
Meucci, G.1
Fasoli, R.2
Saibeni, S.3
-
10
-
-
80053130407
-
Early mucosal healing with infliximab is associated with improved longYterm clinical outcomes in ulcerative colitis
-
Colombel JF, Rutgeerts P, Reinisch W, et al. Early mucosal healing with infliximab is associated with improved longYterm clinical outcomes in ulcerative colitis. Gastroenterology 2011;141(4):1194Y201
-
(2011)
Gastroenterology
, vol.141
, Issue.4
-
-
Colombel, J.F.1
Rutgeerts, P.2
Reinisch, W.3
-
11
-
-
34547503869
-
Mucosal healing in inflammatory bowel disease: Results from a norwegian populationybased cohort
-
IBSEN Grou.p.
-
Frøslie KF, Jahnsen J, Moum BA, Vatn MH. IBSEN Group. Mucosal healing in inflammatory bowel disease: Results from a Norwegian populationYbased cohort. Gastroenterology 2007;133(2):412Y22
-
(2007)
Gastroenterology
, vol.133
, Issue.2
, pp. 412-422
-
-
Frøslie, K.F.1
Jahnsen, J.2
Moum, B.A.3
Vatn, M.H.4
-
12
-
-
84930377906
-
Treat to target: A proposed new paradigm for the management of Crohn's disease
-
[Epub ahead of print]
-
Bouguen G, Levesque BG, Feagan BG, et al. Treat to target: A proposed new paradigm for the management of Crohn's disease. Clin Gastroenterol Hepatol 2013. [Epub ahead of print]
-
(2013)
Clin Gastroenterol Hepatol
-
-
Bouguen, G.1
Levesque, B.G.2
Feagan, B.G.3
-
13
-
-
33847179443
-
A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis
-
D'Haens G, Sandborn WJ, Feagan BG, et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 2007;132(2):763Y86
-
(2007)
Gastroenterology
, vol.132
, Issue.2
, pp. 763-786
-
-
D'Haens, G.1
Sandborn, W.J.2
Feagan, B.G.3
-
14
-
-
80955180936
-
Review article: Defining remission in ulcerative colitis
-
Travis SP, Higgins PD, Orchard T, et al. Review article: Defining remission in ulcerative colitis. Aliment Pharmacol Ther 2011;34(2):113Y24
-
(2011)
Aliment Pharmacol Ther
, vol.34
, Issue.2
, pp. 113-124
-
-
Travis, S.P.1
Higgins, P.D.2
Orchard, T.3
-
15
-
-
84887208189
-
Definition and evaluation of mucosal healing in clinical practice
-
Mazzuoli S, Guglielmi FW, Antonelli E, et al. Definition and evaluation of mucosal healing in clinical practice. Dig Liver Dis 2013;45(12):969Y77
-
(2013)
Dig Liver Dis
, vol.45
, Issue.12
, pp. 69-77
-
-
Mazzuoli, S.1
Guglielmi, F.W.2
Antonelli, E.3
-
16
-
-
75049086190
-
Clinical implications of mucosal healing for the management of ibd
-
Pineton De Chambrun G, PeyrinYBiroulet L, Le'mann M, Colombel JF. Clinical implications of mucosal healing for the management of IBD. Nat Rev Gastroenterol Hepatol 2010;7(1):15Y29
-
(2010)
Nat Rev Gastroenterol Hepatol
, vol.7
, Issue.1
, pp. 15-29
-
-
Pineton De Chambrun, G.1
Peyrin, Y.2
Biroulet, L.3
Le'mann, M.4
Colombel, J.F.5
-
17
-
-
0008690916
-
Cortisone in ulcerative colitis; final report on a therapeutic trial
-
Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 1955;2(4947): 1041Y8
-
(1955)
Br Med J
, vol.2
, Issue.4947
, pp. 1041-1048
-
-
Truelove, S.C.1
Witts, L.J.2
-
18
-
-
0024356033
-
Development and validation of an endoscopic index of the severity for Crohn's disease: A prospective multicentre study
-
Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)
-
Mary JY, Modigliani R. Development and validation of an endoscopic index of the severity for Crohn's disease: A prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut 1989;30(7):983Y9
-
(1989)
Gut
, vol.30
, Issue.7
, pp. 983-989
-
-
Mary, J.Y.1
Modigliani, R.2
-
19
-
-
4744375545
-
Development and validation of a new, simplified endoscopic activity score for crohn's disease: The sesycd
-
Daperno M, D'Haens G, Van Assche G, et al. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: The SESYCD. Gastrointest Endosc 2004;60(4):505Y12
-
(2004)
Gastrointest Endosc
, vol.60
, Issue.4
, pp. 505-512
-
-
Daperno, M.1
D'Haens, G.2
Van Assche, G.3
-
20
-
-
0038574361
-
Review article: Crohn's disease: Monitoring disease activity
-
Sostegni R, Daperno M, Scaglione N, et al. Review article: Crohn's disease: Monitoring disease activity. Aliment Pharmacol Ther 2003;17(Suppl 2):11Y17
-
(2003)
Aliment Pharmacol Ther
, vol.17
, Issue.2
, pp. 11-17
-
-
Sostegni, R.1
Daperno, M.2
Scaglione, N.3
-
21
-
-
84903186353
-
Comparing disease activity indices in ulcerative colitis
-
[Epub ahead of print]
-
Walsh AJ, Ghosh A, Brain AO, et al. Comparing disease activity indices in ulcerative colitis. J Crohns Colitis 2013. [Epub ahead of print]
-
(2013)
J Crohns Colitis
-
-
Walsh, A.J.1
Ghosh, A.2
Brain, A.O.3
-
22
-
-
84857700568
-
Developing an instrument to assess the endoscopic severity of ulcerative colitis: The ulcerative colitis endoscopic index of severity (uceis
-
Travis SP, Schnell D, Krzeski P, et al. Developing an instrument to assess the endoscopic severity of ulcerative colitis: The Ulcerative Colitis Endoscopic Index of Severity (UCEIS). Gut 2012;61(4): 535Y42
-
(2012)
Gut
, vol.61
, Issue.4
, pp. 535-542
-
-
Travis, S.P.1
Schnell, D.2
Krzeski, P.3
-
23
-
-
84879485530
-
The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis
-
Feagan BG, Sandborn WJ, D'Haens G, et al. The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis. Gastroenterology 2013;145(1):149Y57
-
(2013)
Gastroenterology
, vol.145
, Issue.1
, pp. 149-157
-
-
Feagan, B.G.1
Sandborn, W.J.2
D'Haens, G.3
-
24
-
-
84870888253
-
Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measures
-
Samuel S, Bruining DH, Loftus EV Jr, et al. Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measures. Clin Gastroenterol Hepatol 2013;11(1): 49Y54
-
(2013)
Clin Gastroenterol Hepatol
, vol.11
, Issue.1
, pp. 49-54
-
-
Samuel, S.1
Bruining, D.H.2
Loftus Jr., E.V.3
-
25
-
-
34447637292
-
Outcome measurement in clinical trials for Ulcerative Colitis: Towards standardisation
-
Cooney RM, Warren BF, Altman DG, et al. Outcome measurement in clinical trials for Ulcerative Colitis: Towards standardisation. Trials 2007;8:17
-
(2007)
Trials
, vol.8
, pp. 17
-
-
Cooney, R.M.1
Warren, B.F.2
Altman, D.G.3
-
26
-
-
79955859430
-
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: Results of a randomised controlled trial
-
Reinisch W, Sandborn WJ, Hommes DW, et al. Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: Results of a randomised controlled trial. Gut 2011;60(6):780Y7
-
(2011)
Gut
, vol.60
, Issue.6
, pp. 780-787
-
-
Reinisch, W.1
Sandborn, W.J.2
Hommes, D.W.3
-
27
-
-
84886775628
-
Reliability and initial validation of the ulcerative colitis endoscopic index of severity
-
Travis SP, Schnell D, Krzeski P, et al. Reliability and initial validation of the ulcerative colitis endoscopic index of severity. Gastroenterology 2013;145(5): 987Y95
-
(2013)
Gastroenterology
, vol.145
, Issue.5
, pp. 987-995
-
-
Travis, S.P.1
Schnell, D.2
Krzeski, P.3
-
28
-
-
73949148671
-
Comparison of several activity indices for the evaluation of endoscopic activity in UC: InterY and intraobserver consistency
-
Osada T, Ohkusa T, Yokoyama T, et al. Comparison of several activity indices for the evaluation of endoscopic activity in UC: InterY and intraobserver consistency. Inflamm Bowel Dis 2010;16(2):192Y7
-
(2010)
Inflamm Bowel Dis
, vol.16
, Issue.2
, pp. 192-197
-
-
Osada, T.1
Ohkusa, T.2
Yokoyama, T.3
-
29
-
-
78649583974
-
Endoscopic evaluation of crohn's disease activity: Comparison of the cdeis and the sesycd
-
Sipponen T, Nuutinen H, Turunen U, Färkkilä M. Endoscopic evaluation of Crohn's disease activity: Comparison of the CDEIS and the SESYCD. Inflamm Bowel Dis 2010;16(12):2131Y6
-
(2010)
Inflamm Bowel Dis
, vol.16
, Issue.12
, pp. 131-136
-
-
Sipponen, T.1
Nuutinen, H.2
Turunen, U.3
Färkkilä, M.4
-
30
-
-
84872075826
-
Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol
-
Hébuterne X, Lémann M, Bouhnik Y, et al. Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol. Gut 2013;62(2):201Y8
-
(2013)
Gut
, vol.62
, Issue.2
, pp. 201-208
-
-
Hébuterne, X.1
Lémann, M.2
Bouhnik, Y.3
-
31
-
-
84893898345
-
Association between plasma concentrations of certolizumab pegol and endoscopic outcomes of patients with crohn's disease
-
Colombel JF, Sandborn WJ, Allez M, et al. Association Between Plasma Concentrations of Certolizumab Pegol and Endoscopic Outcomes of Patients With Crohn's Disease. Clin Gastroenterol Hepatol 2014; 12(3):423Y31.e1
-
(2014)
Clin Gastroenterol Hepatol
, vol.12
, Issue.3
-
-
Colombel, J.F.1
Sandborn, W.J.2
Allez, M.3
-
32
-
-
83955162272
-
Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped
-
Louis E, Mary JY, VernierYMassouille G, et al. Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped. Gastroenterology 2012; 142(1):63Y70
-
(2012)
Gastroenterology
, vol.142
, Issue.1
, pp. 63-70
-
-
Louis, E.1
Mary, J.Y.2
Vernier, Y.3
Massouille, G.4
-
33
-
-
20444483170
-
A randomized, doubleyblind, controlled withdrawal trial in crohn's disease patients in longyterm remission on azathioprine
-
Lémann M, Mary JY, Colombel JF, et al. A randomized, doubleYblind, controlled withdrawal trial in Crohn's disease patients in longYterm remission on azathioprine. Gastroenterology 2005;128(7): 1812Y18
-
(2005)
Gastroenterology
, vol.128
, Issue.7
, pp. 1812-1818
-
-
Lémann, M.1
Mary, J.Y.2
Colombel, J.F.3
-
34
-
-
80053130432
-
Identifying appropriate dichotomizing points for SESYCD to predict longYterm clinical remission for adalimumabtreated patients with Crohn's disease
-
Reinisch W, Rutgeerts P, Panaccione R, et al. Identifying appropriate dichotomizing points for SESYCD to predict longYterm clinical remission for adalimumabtreated patients with Crohn's disease. J Crohns Colitis 2010;4(1):S31YP045
-
(2010)
J Crohns Colitis
, vol.4
, Issue.1
-
-
Reinisch, W.1
Rutgeerts, P.2
Panaccione, R.3
-
35
-
-
55149096910
-
Defining and validating cutyoff's for the simple endoscopic score for crohn's disease
-
Moskovitz DN, Daperno M, Van assche G, et al. Defining and Validating CutYOff's for the Simple Endoscopic Score for Crohn's Disease. Gastroenterology 2007;132(4): A173YS1097
-
(2007)
Gastroenterology
, vol.132
, Issue.4
-
-
Moskovitz, D.N.1
Daperno, M.2
Vanassche, G.3
-
36
-
-
84886795280
-
Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC
-
Ferrante M, Colombel JF, Sandborn WJ, et al. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC. Gastroenterology 2013;145(5):978Y86
-
(2013)
Gastroenterology
, vol.145
, Issue.5
, pp. 978-986
-
-
Ferrante, M.1
Colombel, J.F.2
Sandborn, W.J.3
-
37
-
-
84886786034
-
Evolution of endoscopic activity scores under placebo therapy in Crohn's disease
-
Ferrante M, Noman M, Vermeire S, et al. Evolution of endoscopic activity scores under placebo therapy in Crohn's disease. Gastroenterology 2010;138:S358
-
(2010)
Gastroenterology
, vol.138
-
-
Ferrante, M.1
Noman, M.2
Vermeire, S.3
-
38
-
-
78649270953
-
Phase i, doubleyblind, randomized, placebocontrolled, doseyescalation study of niy0401 (a fully human antiycd3 monoclonal antibody) in patients with moderate to severe active crohn's disease
-
van Der Woude CJ, Stokkers P, van Bodegraven AA, et al. Phase I, doubleYblind, randomized, placebocontrolled, doseYescalation study of NIY0401 (a fully human antiYCD3 monoclonal antibody) in patients with moderate to severe active Crohn's disease. Inflamm Bowel Dis 2010;16(10):1708Y16
-
(2010)
Inflamm Bowel Dis
, vol.16
, Issue.10
, pp. 708-716
-
-
Van Der Woude, C.J.1
Stokkers, P.2
Van Bodegraven, A.A.3
-
39
-
-
34447297867
-
Endoscopic remission and response in crohn's disease: An objective definition using the cdeis
-
Mary JY, Lemann M, Colombel JF, et al. Endoscopic remission and response in Crohn's disease: An objective definition using the CDEIS. Gut 2005;54:A50
-
(2005)
Gut
, vol.54
-
-
Mary, J.Y.1
Lemann, M.2
Colombel, J.F.3
-
40
-
-
78649907424
-
Endoscopic improvement in patients with active Crohn's disease treated with certolizumab pegol: First results of the Music clinical trials
-
Colombel JF, Lemann M, Bouhnik Y, et al. Endoscopic improvement in patients with active Crohn's disease treated with certolizumab pegol: First results of the Music clinical trials. Gastroenterology 2010;138: S166
-
(2010)
Gastroenterology
, vol.138
-
-
Colombel, J.F.1
Lemann, M.2
Bouhnik, Y.3
-
41
-
-
84862777782
-
Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: Data from the EXTEND trial
-
Rutgeerts P, Van Assche G, Sandborn WJ, et al. Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: Data from the EXTEND trial. Gastroenterology 2012;142:1102Y11
-
(2012)
Gastroenterology
, vol.142
, pp. 102-111
-
-
Rutgeerts, P.1
Van Assche, G.2
Sandborn, W.J.3
-
42
-
-
0036161216
-
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease
-
Sandborn WJ, Feagan BG, Hanauer SB, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology 2002;122(2): 512Y30
-
(2002)
Gastroenterology
, vol.122
, Issue.2
, pp. 512-530
-
-
Sandborn, W.J.1
Feagan, B.G.2
Hanauer, S.B.3
-
43
-
-
0021266269
-
Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery
-
Rutgeerts P, Geboes K, Vantrappen G, et al. Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut 1984;25(6):665Y72
-
(1984)
Gut
, vol.25
, Issue.6
, pp. 665-672
-
-
Rutgeerts, P.1
Geboes, K.2
Vantrappen, G.3
-
44
-
-
0025013473
-
Predictability of the postoperative course of Crohn's disease
-
Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990;99(4):956Y63
-
(1990)
Gastroenterology
, vol.99
, Issue.4
, pp. 956-963
-
-
Rutgeerts, P.1
Geboes, K.2
Vantrappen, G.3
-
45
-
-
4444366271
-
Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease
-
Ardizzone S, Maconi G, Sampietro GM, et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterology 2004;127(3):730Y40
-
(2004)
Gastroenterology
, vol.127
, Issue.3
, pp. 730-740
-
-
Ardizzone, S.1
Maconi, G.2
Sampietro, G.M.3
-
46
-
-
4444353986
-
Postoperative maintenance of Crohn's disease remission with 6Ymercaptopurine, mesalamine, or placebo: A 2Yyear trial
-
Hanauer SB, Korelitz BI, Rutgeerts P, et al. Postoperative maintenance of Crohn's disease remission with 6Ymercaptopurine, mesalamine, or placebo: A 2Yyear trial. Gastroenterology 2004;127(3):723Y9
-
(2004)
Gastroenterology
, vol.127
, Issue.3
, pp. 723-729
-
-
Hanauer, S.B.1
Korelitz, B.I.2
Rutgeerts, P.3
-
47
-
-
33646756180
-
Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: A randomised, double blind, placebo controlled GETAID trial
-
Marteau P, Lemann M, Seksik P, et al. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: A randomised, double blind, placebo controlled GETAID trial. Gut 2006;55(6):842Y7
-
(2006)
Gut
, vol.55
, Issue.6
, pp. 842-847
-
-
Marteau, P.1
Lemann, M.2
Seksik, P.3
-
48
-
-
77953726380
-
Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: Efficacy and safety results of a randomised, doubleYblind, doubleYdummy, multicentre trial
-
Reinisch W, Angelberger S, Petritsch W, et al. Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: Efficacy and safety results of a randomised, doubleYblind, doubleYdummy, multicentre trial. Gut 2010; 59(6):752Y9
-
(2010)
Gut
, vol.59
, Issue.6
, pp. 752-759
-
-
Reinisch, W.1
Angelberger, S.2
Petritsch, W.3
-
49
-
-
0023521441
-
Coated oral 5Yaminosalicylic acid therapy for mildly to moderately active ulcerative colitis A randomized study
-
Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5Yaminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987;317(26):1625Y9
-
(1987)
N Engl J Med
, vol.317
, Issue.26
, pp. 625-629
-
-
Schroeder, K.W.1
Tremaine, W.J.2
Ilstrup, D.M.3
-
50
-
-
73949148671
-
Comparison of several activity indices for the evaluation of endoscopic activity in UC: InterY and intraobserver consistency
-
Osada T, Ohkusa T, Yokoyama T, et al. Comparison of several activity indices for the evaluation of endoscopic activity in UC: InterY and intraobserver consistency. Inflamm Bowel Dis 2010;16(2):192Y7
-
(2010)
Inflamm Bowel Dis
, vol.16
, Issue.2
, pp. 192-197
-
-
Osada, T.1
Ohkusa, T.2
Yokoyama, T.3
-
51
-
-
75549096111
-
Variation between observers in Describing mucosal appearances in proctocolitis
-
Baron JH, Connell AM, LennardYJones JE. Variation between observers in Describing mucosal appearances in proctocolitis. Br Med J 1964;1(5375):89Y92
-
(1964)
Br Med J
, vol.1
-
-
Baron, J.H.1
Connell, A.M.2
Lennard, Y.3
Jones, J.E.4
-
52
-
-
20444469332
-
Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin
-
Feagan BG, Greenberg GR, Wild G, et al. Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin. N Engl J Med 2005;352(24): 2499Y507
-
(2005)
N Engl J Med
, vol.352
, Issue.24
-
-
Feagan, B.G.1
Greenberg, G.R.2
Wild, G.3
-
53
-
-
0024587677
-
Coated mesalazine (5Yaminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomised trial
-
Rachmilewitz D. Coated mesalazine (5Yaminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomised trial. BMJ 1989;298:82Y6
-
(1989)
BMJ
, vol.298
-
-
Rachmilewitz, D.1
-
54
-
-
84865041023
-
Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation
-
Baars JE, Nuij VJ, Oldenburg B, et al. Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation. Inflamm Bowel Dis 2012;18(9):1634Y40
-
(2012)
Inflamm Bowel Dis
, vol.18
, Issue.9
, pp. 1634-1640
-
-
Baars, J.E.1
Nuij, V.J.2
Oldenburg, B.3
-
55
-
-
84856163835
-
Adalimumab induces and maintains clinical remission in patients with moderateYtoYsevere ulcerative colitis
-
Sandborn WJ, Van Assche G, Reinisch W, et al. Adalimumab induces and maintains clinical remission in patients with moderateYtoYsevere ulcerative colitis. Gastroenterology 2012;142(2):257Y65
-
(2012)
Gastroenterology
, vol.142
, Issue.2
, pp. 257-265
-
-
Sandborn, W.J.1
Van Assche, G.2
Reinisch, W.3
-
56
-
-
79957452795
-
Mucosal healing predicts late outcomes after the first course of corticosteroids for newly diagnosed ulcerative colitis
-
Ardizzone S, Cassinotti A, Duca P, et al. Mucosal healing predicts late outcomes after the first course of corticosteroids for newly diagnosed ulcerative colitis. Clin Gastroenterol Hepatol 2011;9(6):483Y9
-
(2011)
Clin Gastroenterol Hepatol
, vol.9
, Issue.6
, pp. 483-489
-
-
Ardizzone, S.1
Cassinotti, A.2
Duca, P.3
-
57
-
-
0025219580
-
Clinical, biological, and endoscopic picture of attacks of crohn's disease evolution on prednisolone groupe d'etude thérapeutique des affections inflammatoires digestives
-
Modigliani R, Mary JY, Simon JF, et al. Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives. Gastroenterology 1990;98(4): 811Y18
-
(1990)
Gastroenterology
, vol.98
, Issue.4
, pp. 811-818
-
-
Modigliani, R.1
Mary, J.Y.2
Simon, J.F.3
-
58
-
-
84888400869
-
Clinical disease activity, cyreactive protein normalisation and mucosal healing in crohn's disease in the sonic trial
-
PeyrinYBiroulet L, Reinisch W, Colombel JF, et al. Clinical disease activity, CYreactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial. Gut 2014;63(1):88Y95
-
(2014)
Gut
, vol.63
, Issue.1
, pp. 88-95
-
-
Peyrin, Y.1
Biroulet, L.2
Reinisch, W.3
Colombel, J.F.4
-
59
-
-
55149092209
-
Relationships between Disease activity and serum and fecal biomarkers in patients with Crohn's disease
-
Jones J, Loftus EV Jr, Panaccione R, et al. Relationships between Disease activity and serum and fecal biomarkers in patients with Crohn's disease. Clin Gastroenterol Hepatol 2008;6(11):1218Y24
-
(2008)
Clin Gastroenterol Hepatol
, vol.6
, Issue.11
, pp. 218-224
-
-
Jones, J.1
Loftus Jr., E.V.2
Panaccione, R.3
-
60
-
-
75449114677
-
Mucosal healing predicts sustained clinical remission in patients with earlyYstage Crohn's disease
-
Baert F, Moortgat L, Van Assche G, et al. Mucosal healing predicts sustained clinical remission in patients with earlyYstage Crohn's disease. Gastroenterology 2010; 138(2):463Y8
-
(2010)
Gastroenterology
, vol.138
, Issue.2
, pp. 463-468
-
-
Baert, F.1
Moortgat, L.2
Van Assche, G.3
-
61
-
-
78650167812
-
Short CDAI: Development and validation of a shortened and simplified Crohn's disease activity index
-
Thia K, Faubion WA Jr, Loftus et al. Short CDAI: Development and validation of a shortened and simplified Crohn's disease activity index. Inflamm Bowel Dis 2011; 17(1):105Y11
-
(2011)
Inflamm Bowel Dis
, vol.17
, Issue.1
, pp. 105-111
-
-
Thia, K.1
Faubion Jr., W.A.2
-
62
-
-
77950814674
-
How to avoid treating irritable bowel syndrome with biologic therapy for inflammatory bowel disease
-
Sandborn WJ. How to avoid treating irritable bowel syndrome with biologic therapy for inflammatory bowel disease. Dig Dis 2009;27(Suppl 1):80Y4
-
(2009)
Dig Dis
, vol.27
, Issue.1
-
-
Sandborn, W.J.1
-
63
-
-
77955419649
-
Irritable bowel syndromeYtype symptoms in patients with inflammatory bowel disease: A real association or reflection of occult inflammation?
-
788
-
Keohane J, O'Mahony C, O'Mahony L, et al. Irritable bowel syndromeYtype symptoms in patients with inflammatory bowel disease: A real association or reflection of occult inflammation?. Am J Gastroenterol 2010;105(8):788, 1789Y94
-
(2010)
Am J Gastroenterol
, vol.105
, Issue.8
, pp. 1789-1794
-
-
Keohane, J.1
O'Mahony, C.2
O'Mahony, L.3
-
64
-
-
80855131632
-
Preliminary examination of the relations between Disease activity, illness perceptions, coping strategies, and psychological morbidity in Crohn's disease guided by the common sense model of illness
-
Knowles SR, Wilson JL, Connell WR, Kamm MA. Preliminary examination of the relations between Disease activity, illness perceptions, coping strategies, and psychological morbidity in Crohn's disease guided by the common sense model of illness. Inflamm Bowel Dis 2011;17(12): 2551Y7
-
(2011)
Inflamm Bowel Dis
, vol.17
, Issue.12
, pp. 2551-2557
-
-
Knowles, S.R.1
Wilson, J.L.2
Connell, W.R.3
Kamm, M.A.4
-
65
-
-
84887133364
-
Mucosal healing in inflammatory bowel disease: Treatment efficacy and predictive factors
-
Papi C, FascìYSpurio F, Rogai F, et al. Mucosal healing in inflammatory bowel disease: Treatment efficacy and predictive factors. Dig Liver Dis 2013;45(12):978Y85
-
(2013)
Dig Liver Dis
, vol.45
, Issue.12
, pp. 78-85
-
-
Papi, C.1
Fasci, Y.2
Spurio, F.3
Rogai, F.4
-
66
-
-
79955555545
-
The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease
-
Lewis JD. The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. Gastroenterology 2011; 140(6):1817Y26
-
(2011)
Gastroenterology
, vol.140
, Issue.6
, pp. 1817-1826
-
-
Lewis, J.D.1
-
67
-
-
84862524860
-
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
-
D'Haens G, Ferrante M, Vermeire S, et al. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. Inflamm Bowel Dis 2012;18(12): 2218Y24
-
(2012)
Inflamm Bowel Dis
, vol.18
, Issue.12
, pp. 2218-2224
-
-
D'Haens, G.1
Ferrante, M.2
Vermeire, S.3
-
68
-
-
84876353833
-
Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases
-
Nancey S, Boschetti G, Moussata D, et al. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases. Inflamm Bowel Dis 2013;19(5):1043Y52
-
(2013)
Inflamm Bowel Dis
, vol.19
, Issue.5
, pp. 1043-1052
-
-
Nancey, S.1
Boschetti, G.2
Moussata, D.3
-
69
-
-
34447302288
-
Imaging of the small bowel in Crohn's disease: A review of old and new techniques
-
Saibeni S, Rondonotti E, Iozzelli A, et al. Imaging of the small bowel in Crohn's disease: A review of old and new techniques. World J Gastroenterol 2007;13(24):3279Y87
-
(2007)
World J Gastroenterol
, vol.13
, Issue.24
, pp. 279-287
-
-
Saibeni, S.1
Rondonotti, E.2
Iozzelli, A.3
-
70
-
-
84878643775
-
Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidenceYbased consensus guidelines
-
Panes J, Bouhnik Y, Reinisch W, et al. Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidenceYbased consensus guidelines. J Crohns Colitis 2013;7(7): 556Y85
-
(2013)
J Crohns Colitis
, vol.7
, Issue.7
, pp. 556-585
-
-
Panes, J.1
Bouhnik, Y.2
Reinisch, W.3
-
71
-
-
79959380672
-
Systematic review: The use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease
-
Panés J, Bouzas R, Chaparro M, et al. Systematic review: The use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease. Aliment Pharmacol Ther 2011;34(2): 125Y45
-
(2011)
Aliment Pharmacol Ther
, vol.34
, Issue.2
, pp. 125-145
-
-
Panés, J.1
Bouzas, R.2
Chaparro, M.3
-
72
-
-
79960245749
-
Magnetic resonance imaging for evaluation of Crohn's disease: Validation of parameters of severity and quantitative index of activity
-
Rimola J, Ordás I, Rodriguez S, et al. Magnetic resonance imaging for evaluation of Crohn's disease: Validation of parameters of severity and quantitative index of activity. Inflamm Bowel Dis 2011;17(8):1759Y68
-
(2011)
Inflamm Bowel Dis
, vol.17
, Issue.8
, pp. 1759-1768
-
-
Rimola, J.1
Ordás, I.2
Rodriguez, S.3
-
73
-
-
84885592467
-
Diagnostic accuracy of magnetic resonance colonography for the evaluation of disease activity and severity in ulcerative colitis: A prospective study
-
Ordás I, Rimola J, GarcíaYBosch O, et al. Diagnostic accuracy of magnetic resonance colonography for the evaluation of disease activity and severity in ulcerative colitis: A prospective study. Gut 2013;62(11): 1566Y72
-
(2013)
Gut
, vol.62
, Issue.11
, pp. 1566-1572
-
-
Ordás, I.1
Rimola, J.2
García, Y.3
Bosch, O.4
-
74
-
-
84880629271
-
Accuracy of smallYintestine contrast ultrasonography, compared with computed tomography enteroclysis, in characterizing lesions in patients with Crohn's disease
-
Calabrese E, Zorzi F, Onali S, et al. Accuracy of smallYintestine contrast ultrasonography, compared with computed tomography enteroclysis, in characterizing lesions in patients with Crohn's disease. Clin Gastroenterol Hepatol 2013;11(8): 950Y5
-
(2013)
Clin Gastroenterol Hepatol
, vol.11
, Issue.8
, pp. 950-955
-
-
Calabrese, E.1
Zorzi, F.2
Onali, S.3
-
75
-
-
84893915665
-
Adalimumab induces deep remission in patients with crohn's disease
-
e5
-
Colombel JF, Rutgeerts PJ, Sandborn WJ, et al. Adalimumab Induces Deep Remission in Patients With Crohn's Disease. Clin Gastroenterol Hepatol 2014;12(3):414Y22. e5
-
(2014)
Clin Gastroenterol Hepatol
, vol.12
, Issue.3
, pp. 414-422
-
-
Colombel, J.F.1
Rutgeerts, P.J.2
Sandborn, W.J.3
-
76
-
-
84930375597
-
Treat to target: A proposed new paradigm for the management of Crohn's disease
-
Epub ahead of print]
-
Bouguen G, Levesque BG, Feagan BG, et al. Treat to target: A proposed new paradigm for the management of Crohn's disease. Clin Gastroenterol Hepatol 2013. [Epub ahead of print]
-
(2013)
Clin Gastroenterol Hepatol
-
-
Bouguen, G.1
Levesque, B.G.2
Feagan, B.G.3
-
77
-
-
84888121508
-
Mucosal healing and deep remission: What does it mean?
-
Rogler G, Vavricka S, Schoepfer A, Lakatos PL. Mucosal healing and deep remission: What does it mean?. World J Gastroenterol 2013;19(43):7552Y60
-
(2013)
World J Gastroenterol
, vol.19
, Issue.43
, pp. 552-560
-
-
Rogler, G.1
Vavricka, S.2
Schoepfer, A.3
Lakatos, P.L.4
-
78
-
-
80053133374
-
Results from the 2nd Scientific Workshop of the ECCO (I): Impact of mucosal healing on the course of inflammatory bowel disease
-
Peyrin Y. Biroulet L, Ferrante M, Magro F, et al. Results from the 2nd Scientific Workshop of the ECCO (I): Impact of mucosal healing on the course of inflammatory bowel disease. J Crohns Colitis 2011;5(5):477Y83
-
(2011)
J Crohns Colitis
, vol.5
, Issue.5
, pp. 477-483
-
-
Peyrin, Y.1
Biroulet, L.2
Ferrante, M.3
Magro, F.4
-
79
-
-
70350172248
-
Mucosal healing predicts longYterm outcome of maintenance therapy with infliximab in Crohn's disease
-
Schnitzler F, Fidder H, Ferrante M, et al. Mucosal healing predicts longYterm outcome of maintenance therapy with infliximab in Crohn's disease. Inflamm Bowel Dis 2009; 15(9):1295Y301
-
(2009)
Inflamm Bowel Dis
, vol.15
, Issue.9
-
-
Schnitzler, F.1
Fidder, H.2
Ferrante, M.3
-
80
-
-
77950988234
-
Infliximab, azathioprine, or combination therapy for Crohn's disease
-
Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 2010;362(15):1383Y95
-
(2010)
N Engl J Med
, vol.362
, Issue.15
, pp. 383-395
-
-
Colombel, J.F.1
Sandborn, W.J.2
Reinisch, W.3
-
81
-
-
32944461717
-
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease
-
Rutgeerts P, Diamond RH, Bala M, et al. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease. Gastrointest Endosc 2006;63(3):433Y42
-
(2006)
Gastrointest Endosc
, vol.63
, Issue.3
, pp. 433-442
-
-
Rutgeerts, P.1
Diamond, R.H.2
Bala, M.3
-
82
-
-
9344253340
-
Cancer surveillance in longstanding ulcerative colitis: Endoscopic appearances help predict cancer risk
-
Rutter MD, Saunders BP, Wilkinson KH, et al. Cancer surveillance in longstanding ulcerative colitis: Endoscopic appearances help predict cancer risk. Gut 2004;53(12): 1813Y16
-
(2004)
Gut
, vol.53
-
-
Rutter, M.D.1
Saunders, B.P.2
Wilkinson, K.H.3
-
83
-
-
84878705859
-
Clinical study of the relation between mucosal healing and longYterm outcomes in ulcerative colitis
-
Yokoyama K, Kobayashi K, Mukae M, et al. Clinical study of the relation between mucosal healing and longYterm outcomes in ulcerative colitis. Gastroenterol Res Pract 2013;2013:192794
-
(2013)
Gastroenterol Res Pract
, vol.2013
, pp. 192794
-
-
Yokoyama, K.1
Kobayashi, K.2
Mukae, M.3
-
84
-
-
28844473957
-
Infliximab for induction and maintenance therapy for ulcerative colitis
-
Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005;353(23):2462Y76
-
(2005)
N Engl J Med
, vol.353
, Issue.23
, pp. 462-476
-
-
Rutgeerts, P.1
Sandborn, W.J.2
Feagan, B.G.3
-
85
-
-
84870603610
-
Ulcerative colitis: UCCIS - A reproducible tool to assess mucosal healing
-
Neumann H, Neurath MF. Ulcerative colitis: UCCIS - A reproducible tool to assess mucosal healing. Nat Rev Gastroenterol Hepatol 2012;9(12):692Y4
-
(2012)
Nat Rev Gastroenterol Hepatol
, vol.9
, Issue.12
-
-
Neumann, H.1
Neurath, M.F.2
-
87
-
-
84884175393
-
European consensus on the histopathology of inflammatory bowel disease
-
Magro F, Langner C, Driessen A, et al. European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis 2013;7(10):827Y51
-
(2013)
J Crohns Colitis
, vol.7
, Issue.10
, pp. 27-51
-
-
Magro, F.1
Langner, C.2
Driessen, A.3
-
88
-
-
0026065160
-
Microscopic activity in ulcerative colitis: What does it mean?
-
Riley SA, Mani V, Goodman MJ, et al. Microscopic activity in ulcerative colitis: What does it mean?. Gut 1991;32(2):174Y8
-
(1991)
Gut
, vol.32
, Issue.2
, pp. 174-178
-
-
Riley, S.A.1
Mani, V.2
Goodman, M.J.3
-
89
-
-
0345329373
-
Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis
-
Mathy C, Schneider K, Chen YY, et al. Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis. Inflamm Bowel Dis 2003;9(6):351Y5
-
(2003)
Inflamm Bowel Dis
, vol.9
, Issue.6
, pp. 351-355
-
-
Mathy, C.1
Schneider, K.2
Chen, Y.Y.3
-
90
-
-
10744221150
-
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis
-
Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004;126(2):451Y9
-
(2004)
Gastroenterology
, vol.126
, Issue.2
, pp. 451-459
-
-
Rutter, M.1
Saunders, B.2
Wilkinson, K.3
-
91
-
-
84887997494
-
Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: A caseYcontrol study
-
Rubin DT, Huo D, Kinnucan JA, et al. Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: A caseYcontrol study. Clin Gastroenterol Hepatol 2013;11(12):1601Y8
-
(2013)
Clin Gastroenterol Hepatol
, vol.11
, Issue.12
, pp. 601-608
-
-
Rubin, D.T.1
Huo, D.2
Kinnucan, J.A.3
-
92
-
-
84864067072
-
Correlation of two capsule endoscopy scoring systems with fecal calprotectin: Does it really matter?
-
Gurudu SR, Leighton JA. Correlation of two capsule endoscopy scoring systems with fecal calprotectin: Does it really matter?. Dig Dis Sci 2012;57:827Y9
-
(2012)
Dig Dis Sci
, vol.57
, pp. 827-829
-
-
Gurudu, S.R.1
Leighton, J.A.2
-
93
-
-
70249118593
-
Role of smallYbowel endoscopy in the management of patients with inflammatory bowel disease: An international OMEDYECCO consensus
-
Bourreille A, Ignjatovic A, Aabakken L, et al. Role of smallYbowel endoscopy in the management of patients with inflammatory bowel disease: An international OMEDYECCO consensus. Endoscopy 2009;41(7):618Y37
-
(2009)
Endoscopy
, vol.41
, Issue.7
, pp. 618-637
-
-
Bourreille, A.1
Ignjatovic, A.2
Aabakken, L.3
-
95
-
-
0842286558
-
Initial experience with wireless capsule enteroscopy in the diagnosis and management of inflammatory bowel disease
-
Mow WS, Lo SK, Targan SR, et al. Initial experience with wireless capsule enteroscopy in the diagnosis and management of inflammatory bowel disease. Clin Gastroenterol Hepatol 2004;2(1):31Y40
-
(2004)
Clin Gastroenterol Hepatol
, vol.2
, Issue.1
, pp. 31-40
-
-
Mow, W.S.1
Lo, S.K.2
Targan, S.R.3
-
96
-
-
44449151188
-
Assessment and validation of the new capsule endoscopy crohn's disease activity index (cecdai
-
Gal E, Geller A, Fraser G, et al. Assessment and validation of the new capsule endoscopy Crohn's disease activity index (CECDAI). Dig Dis Sci 2008;53(7):1933Y7
-
(2008)
Dig Dis Sci
, vol.53
, Issue.7
, pp. 1933-1937
-
-
Gal, E.1
Geller, A.2
Fraser, G.3
-
97
-
-
84455202340
-
Validation of the capsule endoscopy crohn's disease activity index (cecdai or niv score): A multicenter prospective study
-
Niv Y, Ilani S, Levi Z, et al. Validation of the Capsule Endoscopy Crohn's Disease Activity Index (CECDAI or Niv score): A multicenter prospective study. Endoscopy 2012;44(1):21Y6
-
(2012)
Endoscopy
, vol.44
, Issue.1
-
-
Niv, Y.1
Ilani, S.2
Levi, Z.3
-
98
-
-
37149034630
-
Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change
-
Gralnek IM, Defranchis R, Seidman E, et al. Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change. Aliment Pharmacol Ther 2008;27(2):146Y54
-
(2008)
Aliment Pharmacol Ther
, vol.27
, Issue.2
, pp. 146-154
-
-
Gralnek, I.M.1
Defranchis, R.2
Seidman, E.3
-
99
-
-
84862189184
-
Lewis score: A useful clinical tool for patients with suspected crohn's disease submitted to capsule endoscopy
-
Rosa B, Moreira MJ, Rebelo A, Cotter J. Lewis Score: A useful clinical tool for patients with suspected Crohn's Disease submitted to capsule endoscopy. J Crohns Colitis 2012;6(6):692Y7
-
(2012)
J Crohns Colitis
, vol.6
, Issue.6
, pp. 692-697
-
-
Rosa, B.1
Moreira, M.J.2
Rebelo, A.3
Cotter, J.4
-
100
-
-
77953716757
-
Video capsule endoscopy in inflammatory bowel disease: Past, present, and future redux
-
Swaminath A, Legnani P, Kornbluth A. Video capsule endoscopy in inflammatory bowel disease: Past, present, and future redux. Inflamm Bowel Dis 2010;16(7): 1254Y62
-
(2010)
Inflamm Bowel Dis
, vol.16
, Issue.7
, pp. 1254-1262
-
-
Swaminath, A.1
Legnani, P.2
Kornbluth, A.3
-
103
-
-
84884659237
-
Advances in novel diagnostic endoscopic imaging techniques in inflammatory bowel disease
-
Iacucci M, Panaccione R, Ghosh S. Advances in novel diagnostic endoscopic imaging techniques in inflammatory bowel disease. Inflamm Bowel Dis 2013;19(4): 873Y80
-
(2013)
Inflamm Bowel Dis
, vol.19
, Issue.4
, pp. 873-880
-
-
Iacucci, M.1
Panaccione, R.2
Ghosh, S.3
-
105
-
-
84884639631
-
Virtual chromoendoscopy for prediction of severity and disease extent in patients with inflammatory bowel disease: A randomized controlled study
-
Neumann H, Vieth M, Günther C, et al. Virtual chromoendoscopy for prediction of severity and disease extent in patients with inflammatory bowel disease: A randomized controlled study. Inflamm Bowel Dis 2013; 19(9):1935Y42
-
(2013)
Inflamm Bowel Dis
, vol.19
, Issue.9
, pp. 1935-1942
-
-
Neumann, H.1
Vieth, M.2
Günther, C.3
-
106
-
-
84885960393
-
Review article: Newer optical and digital chromoendoscopy techniques vs. DyeYbased chromoendoscopy for diagnosis and surveillance in inflammatory bowel disease
-
Tontini GE, Vecchi M, Neurath MF, Neumann H. Review article: Newer optical and digital chromoendoscopy techniques vs. dyeYbased chromoendoscopy for diagnosis and surveillance in inflammatory bowel disease. Aliment Pharmacol Ther 2013; 38(10):1198Y208
-
(2013)
Aliment Pharmacol Ther
, vol.38
, Issue.10
, pp. 198-208
-
-
Tontini, G.E.1
Vecchi, M.2
Neurath, M.F.3
Neumann, H.4
-
107
-
-
33845463326
-
Pit patterns in rectal mucosa assessed by magnifying colonoscope are predictive of relapse in patients with quiescent ulcerative colitis
-
Nishio Y, Ando T, Maeda O, et al. Pit patterns in rectal mucosa assessed by magnifying colonoscope are predictive of relapse in patients with quiescent ulcerative colitis. Gut 2006;55(12):1768Y73
-
(2006)
Gut
, vol.55
, Issue.12
, pp. 768-773
-
-
Nishio, Y.1
Ando, T.2
Maeda, O.3
-
108
-
-
84888126513
-
Beyond white light endoscopy: The role of optical biopsy in inflammatory bowel disease
-
Liu J, Dlugosz A, Neumann H. Beyond white light endoscopy: The role of optical biopsy in inflammatory bowel disease. World J Gastroenterol 2013;19(43):7544Y51
-
(2013)
World J Gastroenterol
, vol.19
, Issue.43
, pp. 544-551
-
-
Liu, J.1
Dlugosz, A.2
Neumann, H.3
-
109
-
-
84903206360
-
Confocal laser endomicroscopy for prediction of disease relapse in ulcerative colitis: A pilot study
-
Epub ahead of print]
-
Buda A, Hatem G, Neumann H, et al. Confocal laser endomicroscopy for prediction of disease relapse in ulcerative colitis: A pilot study. J Crohns Colitis 2013. [Epub ahead of print]
-
(2013)
J Crohns Colitis
-
-
Buda, A.1
Hatem, G.2
Neumann, H.3
-
110
-
-
77955486592
-
Confocal laser endomicroscopy: Technical advances and clinical applications
-
Neumann H, Kiesslich R, Wallace MB, Neurath MF. Confocal laser endomicroscopy: Technical advances and clinical applications. Gastroenterology 2010; 139(2):388Y92
-
(2010)
Gastroenterology
, vol.139
, Issue.2
, pp. 388-392
-
-
Neumann, H.1
Kiesslich, R.2
Wallace, M.B.3
Neurath, M.F.4
-
112
-
-
84869224255
-
Assessment of Crohn's disease activity by confocal laser endomicroscopy
-
Neumann H, Vieth M, Atreya R, et al. Assessment of Crohn's disease activity by confocal laser endomicroscopy. Inflamm Bowel Dis 2012;18(12):2261Y9
-
(2012)
Inflamm Bowel Dis
, vol.18
, Issue.12
, pp. 261-269
-
-
Neumann, H.1
Vieth, M.2
Atreya, R.3
-
113
-
-
77953233104
-
Classification of inflammation activity in ulcerative colitis by confocal laser endomicroscopy
-
Li CQ, Xie XJ, Yu T, et al. Classification of inflammation activity in ulcerative colitis by confocal laser endomicroscopy. Am J Gastroenterol 2010;105(6):1391Y6
-
(2010)
Am J Gastroenterol
, vol.105
, Issue.6
, pp. 1391-1396
-
-
Li, C.Q.1
Xie, X.J.2
Yu, T.3
-
114
-
-
84862880940
-
Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease
-
Kiesslich R, Duckworth CA, Moussata D, et al. Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease. Gut 2012;61(8):1146Y53.
-
(2012)
Gut
, vol.61
, Issue.8
, pp. 1146-1153
-
-
Kiesslich, R.1
Duckworth, C.A.2
Moussata, D.3
|